#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10634	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2253	463.9	0	.	n	.	0	C227T	SNP	227	227	C	479	479	T	546	T,C	277,258	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10634	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2253	463.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1436	1436	C	565	C,T	551,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10634	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2253	463.9	0	HET	.	.	.	C207T,G	.	207	207	C	459	459	C	573	C,T,G	428,133,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10634	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2253	463.9	0	HET	.	.	.	C451T	.	451	451	C	703	703	C	571	C,T	277,277	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19872	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3670	536.1	0	.	n	.	0	T695C	SNP	695	695	T	1080	1080	C	622	C	607	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19872	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3670	536.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	2023	2023	G	635	G,A	305,318	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19872	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3670	536.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2356	2356	C	647	C,G	620,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19872	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3670	536.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2430	2430	A	650	A	637	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19872	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3670	536.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2982	2982	C	540	C	527	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1406	folP	855	855	100.0	folP.l15.c4.ctg.1	1554	89.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1078	1080	AGC	154;153;148	A;G;C	150;149;145	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4258	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3343	125.9	1	SNP	p	S91F	1	.	.	271	273	TTC	536	538	TTC	139;141;141	T;T;C	136;140;140	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4258	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3343	125.9	1	SNP	p	G95N	0	.	.	283	285	GGC	548	550	GGC	135;132;128	G;G;C	134;132;126	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4258	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3343	125.9	1	SNP	p	D95G	1	.	.	283	285	GGC	548	550	GGC	135;132;128	G;G;C	134;132;126	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1252	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1352	91.7	1	SNP	p	G45D	0	.	.	133	135	GGC	477	479	GGC	170;168;168	G;G;C	164;161;161	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	636	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	928	67.3	0	.	n	.	0	A197.	DEL	197	197	A	543	543	A	136	A	131	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3646	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	121.8	1	SNP	p	D86N	0	.	.	256	258	GAC	621	623	GAC	145;145;147	G;A;C	143;138;145	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3646	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	121.8	1	SNP	p	R87W	0	.	.	259	261	CGT	624	626	CGT	149;151;152	C;G;T	147;150;148	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3646	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	121.8	1	SNP	p	S87R	1	.	.	259	261	CGT	624	626	CGT	149;151;152	C;G;T	147;150;148	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3646	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	121.8	1	SNP	p	R87I	0	.	.	259	261	CGT	624	626	CGT	149;151;152	C;G;T	147;150;148	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3646	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	121.8	1	SNP	p	S88P	0	.	.	262	264	TCC	627	629	TCC	153;153;153	T;C,G;C	149;151,1;150	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2996	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2588	114.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1536	1538	GGC	155;152;153	G;G;C	151;148;147	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1247	1249	GCC	191;191;189	G;C;C	186;186;180	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1250	1252	ATG	189;188;190	A;T;G,T	184;182;182,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1262	1264	ACC	183;184;184	A;C;C	171;177;175	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1262	1264	ACC	183;184;184	A;C;C	171;177;175	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1763	1765	ACC	160;160;158	A;C;C	151;156;153	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1817	1819	GCG	151;151;149	G,A,T;C;G	144,1,1;145;144	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1817	1819	GCG	151;151;149	G,A,T;C;G	144,1,1;145;144	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1940	1942	GGT	106;104;102	G;G;T	105;103;101	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1949	1951	AGC	91;91;90	A;G;C	89;89;89	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2368	128.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1967	1969	CCG	80;79;78	C,G;C,G;G	69,7;72,2;65	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4144	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3117	131.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1604	1606	CCG	138;139;139	C,A;C;G	132,1;139;130	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1908	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1812	103.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	620	620	C	134	C	125	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2016	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1585	126.0	1	SNP	p	G120K	1	.	.	358	360	AAG	669	671	AAG	161;160;159	A;A;G	159;160;152	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2016	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1585	126.0	1	SNP	p	N121D	0	.	.	361	363	AAC	672	674	AAC	162;162;160	A;A;C	160;161;157	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2016	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1585	126.0	1	SNP	p	A121N	1	.	.	361	363	AAC	672	674	AAC	162;162;160	A;A;C	160;161;157	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6902	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4877	139.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	832	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1139	71.8	1	SNP	p	V57M	1	.	.	169	171	ATG	617	619	ATG	144;145;145	A,T;T;G,T	141,1;143;142,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
